Bayer Partners with Google Cloud to Develop AI-Powered Medical Imaging Solutions
Germany’s pharmaceutical and life sciences giant Bayer (ETR: BAYN) has joined forces with US technology...
Germany’s pharmaceutical and life sciences giant Bayer (ETR: BAYN) has joined forces with US technology...
Apeloa Pharmaceutical Co., Ltd (SHE: 000739), a prominent player in the Chinese pharmaceutical industry, has...
Suzhou SmartNuclide Biopharmaceutical Co., Ltd, a leading developer of radiopharmaceuticals in China, has announced the...
US-based biotechnology company Arnatar Therapeutics has successfully closed a $50 million Series A financing round,...
China-based biotech company Transcenta Holdings Ltd (HKG: 6628) has announced a strategic agreement with Agilent...
UK life sciences investment firm Medicxi has taken the lead in a $62 million Series...
German pharmaceutical giant Merck (ETR: MRK) has entered into a strategic collaboration with Caris Life...
Healthcare conglomerate Johnson & Johnson (J&J; NYSE: JNJ) has announced the acquisition of Shockwave Medical...
Sino Biopharmaceutical Ltd (HKG: 1177) has announced a strategic partnership with Germany’s Boehringer Ingelheim (BI)...
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a prominent player in the medical diagnostics space,...
Shanghai-based Applied Protein Technology (APTBIO), a pioneer in life science technology services driven by mass...
Germany-based Siemens Healthineers AG, along with its subsidiary Siemens China, has entered into a strategic...
Japanese pharmaceutical company Eisai (TYO: 4523) has entered into a cooperation agreement with China Resource...
Denmark-based biotech Genmab A/S (NASDAQ: GMAB) has announced a significant all-cash acquisition of Sino-US biotech...
Gilead Sciences (NASDAQ: GILD) has announced a two-year extension of its 2019 collaboration with Nurix...
China-based RemeGen (HKG: 9995) has announced plans to raise RMB 2.55 billion (approximately USD 280.5...
Legend Biotech Corporation (NASDAQ: LEGN), a leading Chinese biotech firm, and its U.S. partner Janssen...
China Medical System Holdings (CMS; HKG: 0867) has announced a new cooperation and licensing agreement...
ETERN Therapeutics, a Shanghai-based developer of small-molecule anti-tumor drugs, has announced the commencement of a...
Shanghai has unleashed a flurry of policy-backed project signings and initiatives, marking a significant boost...